Showing results (51-60 of 212) with videos related to
Sort By:
Pageof 22
Molecular Pharmaceutics|March 6, 2018
Click-Mediated Pretargeted Radioimmunotherapy of Colorectal CarcinomaRosemery Membreno, Brendon E Cook, Kimberly Fung, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2022
Antibody Engineering for Nuclear Imaging and RadioimmunotherapyCindy Rodriguez, Samantha Delaney, Samantha M Sarrett, et al.Medical Physics|March 26, 2025
Comparative analysis of auger electron emission libraries and Monte Carlo track structure codes for DNA-targeted auger electron therapyAlexandre França Velo, Lukas Carter, Michael Bellamy, et al.Nuclear Medicine and Biology|July 2, 2011
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancerBrian M Zeglis, NagaVaraKishore Pillarsetty, Vadim Divilov, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
The Impact of FcγRI Binding on Immuno-PETDelphine Vivier, Sai Kiran Sharma, Pierre Adumeau, et al.Molecular Pharmaceutics|December 8, 2020
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain PeptideGu Xiao, George K Annor, Kimberly Fung, et al.Dalton Transactions (Cambridge, England : 2003)|October 10, 2013
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177LuEric W Price, Brian M Zeglis, Jason S Lewis, et al.Bioconjugate Chemistry|March 26, 2026
Linker Chemistry in Radiopharmaceutical DesignAva Stoddard, Kiarra Furey, Gina Dehlavi, et al.Chemical Communications (Cambridge, England)|May 4, 2021
Fluorine-18 labelled Ruppert-Prakash reagent ([18F]Me3SiCF3) for the synthesis of 18F-trifluoromethylated compoundsAnna Pees, Maria J W D Vosjan, Neil Vasdev, et al.Analytica Chimica Acta|March 1, 2026
Microscale native size exclusion chromatography high resolution mass spectrometry for the determination of the chelator-to-antibody ratio of immunoconjugatesAnnika A M van der Zon, Bram Weijers, Danielle J Vugts, et al.Pageof 22